Pesquisas alternativas:
doses developing » does developing (Expandir a Pesquisa), cases developing (Expandir a Pesquisa), costs developing (Expandir a Pesquisa)
developing type » developing novel (Expandir a Pesquisa)
drug doses » drug disease (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
drug de » drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
doses developing » does developing (Expandir a Pesquisa), cases developing (Expandir a Pesquisa), costs developing (Expandir a Pesquisa)
developing type » developing novel (Expandir a Pesquisa)
drug doses » drug disease (Expandir a Pesquisa)
drug dose » drug dosage (Expandir a Pesquisa)
drug de » drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
1
Por Tácio de Mendonça Lima, Millena Padela da Silva, Luan Donato Silva Luz, Thais Cristina Amorim Estevão Soares, Etielle Silvestre Dantas, Gabriela Felix Teixeira, Rafael Henrique de Souza Costa, Sérgio Henrique Monte Santo Andrade
Publicado em 2022-03-01
Assuntos:
“...Drug dosage calculation...”Publicado em 2022-03-01
Obter o texto integral
Artigo
2
“... termination of drug development or withdrawal of drugs from the market. Management of such interactions...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
3
Por Hansen, Aaron R., Cook, Natalie, Ricci, M. Stacey, Razak, Albiruni, Le Tourneau, Christophe, McKeever, Kathleen, Roskos, Lorin, Dixit, Rakesh, Siu, Lillian L., Hinrichs, Mary Jane
Publicado no Oncologist (2015)
Assuntos:
“...New Drug Development and Clinical Pharmacology...”Publicado no Oncologist (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
“... using the following terms: obesity, morbid obesity, overweight, pharmacokinetics, drug, dose, kidney...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Johnson, Amy J., Lucas, David M., Muthusamy, Natarajan, Smith, Lisa L., Edwards, Ryan B., De Lay, Michael D., Croce, Carlo M., Grever, Michael R., Byrd, John C.
Publicado em 2006
“...Drug development in human chronic lymphocytic leukemia (CLL) has been limited by lack of a suitable...”Publicado em 2006
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
“... development of skin lesions, mortality, and latency was related to the dose of ACV-resistant virus used...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
7
Por Demonceau, Jenny, Ruppar, Todd, Kristanto, Paulus, Hughes, Dyfrig A., Fargher, Emily, Kardas, Przemyslaw, De Geest, Sabina, Dobbels, Fabienne, Lewek, Pawel, Urquhart, John, Vrijens, Bernard
Publicado em 2013
“... of strategies and components thereof that improve implementation of the prescribed drug dosing regimen...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
“...Background. Drug resistance development in the human immunodeficiency virus (HIV)-infected...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
Por Kenney, Jessica, Derby, Nina, Aravantinou, Meropi, Kleinbeck, Kyle, Frank, Ines, Gettie, Agegnehu, Grasperge, Brooke, Blanchard, James, Piatak, Michael, Lifson, Jeffrey D., Zydowsky, Thomas M., Robbiani, Melissa
Publicado em 2014
Assuntos:
“...Preclinical Studies/Drug Development...”Publicado em 2014
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“... of therapeutic modalities of newly developed anti-inflammatory drugs. The pigs were sensitized with oxazolone, re...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Kerbel, Robert S.
Publicado em 2007
“... low dose chemotherapy. We have been studying the hypothesis that some chemotherapy drugs at maximum...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
12
“... immunodeficiency virus type 1 polymerase region. Furthermore, other novel non-thymine nucleoside reverse...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“...<p>Abstract</p> <p>Background</p> <p>Type 2 diabetes is a risk factor for Alzheimer's disease (AD...”
Obter o texto integral
Obter o texto integral
Artigo
14
Assuntos:
“...Review Article/Theme: Role of Biomarkers in Drug Development/Guest Editors: Brian P. Booth...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Bryan T Mayer, Allan C deCamp, Yunda Huang, Joshua T Schiffer, Raphael Gottardo, Peter B Gilbert, Daniel B Reeves
Publicado em 2022-04-01
“... the composition, or dose ratio, of combination bNAb therapies for future clinical studies. We developed a model...”Publicado em 2022-04-01
Obter o texto integral
Artigo
16
Por Roberta Simone Andreazza, Mauro Silveira De Castro, Patrícia Sippel Köche, Isabela Heineck
Publicado em 2011-12-01
Assuntos:
“...Servicio de urgencias...”Publicado em 2011-12-01
Obter o texto integral
Artigo
17
“... delay and clonogenic cell survival during repeated drug treatment. A slow rate of resistance development...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
18
“...Antibody drug conjugates (ADCs) are an emerging new class of targeted therapeutics for cancer...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Wang, Wei-Peng, Ho, Pui Yan, Chen, Qiu-Xia, Addepalli, Balasubrahmanyam, Limbach, Patrick A., Li, Mei-Mei, Wu, Wen-Juan, Jilek, Joseph L., Qiu, Jing-Xin, Zhang, Hong-Jian, Li, Tianhong, Wun, Theodore, White, Ralph DeVere, Lam, Kit S., Yu, Ai-Ming
Publicado no J Pharmacol Exp Ther (2015)
Assuntos:
“...Drug Discovery and Translational Medicine...”Publicado no J Pharmacol Exp Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
20